Interestingly, studies have reported that CD9 and CXCL12 are associated in a CD9/CXCL12/CXCR4 signaling pathway, and activation of this pathway is linked to increased tumor invasion, metastasis, and chemoresistance [50, 51]. Here, CD9 is linked to neoplasm.